Short-term and long-term evaluation of selective serotonin reuptake inhibitors in the treatment of panic disorder: fluoxetine vs citalopram
✍ Scribed by Mario Amore; Katia Magnani; Marziano Cerisoli; Giuseppe Ferrari
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 83 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
This double-blind study evaluates the ecacy and tolerability of ¯uoxetine and citalopram in the acute and long-term treatment of panic disorder in 42 patients meeting DSM-IV criteria for panic disorder with or without agoraphobia. Fluoxetine and citalopram showed similar ecacy in the treatment of panic disorder patients. On the basis of HRSA and PASS mean score evaluation, ¯uoxetine was more rapid than citalopram in reducing generalized anxiety symptoms, spontaneous panic attacks and anticipatory anxiety. Fluoxetine appeared to be eective at a dosage of 10 mg/day, while citalopram reached the same ecacy at a dosage of 30 mg/day. Long-term evaluation has demonstrated high rates of persistent full remission with both drugs.